Optifarm
- 0407.818.781
- BE0407818781
- Heldenlaan 16, 9620 Zottegem
- See the 3 companies at this address
- 28 December 1970
Profile
Official information from the CBE (FPS Economy).
Optifarm is a Belgian company (Société à responsabilité limitée) whose registered office is established at 9620 Zottegem. Its main activity falls under “Commerce de détail de produits pharmaceutiques” (NACE 47730).
- Legal form
- Société à responsabilité limitée
- Legal situation
- Situation normale
- Date of incorporation
- 28 December 1970
- Main activity (NACE)
- 47730Commerce de détail de produits pharmaceutiques
An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more
Secondary activities
8 additional NACE codes declared.
- 52310Pharmacies
- 47730Commerce de détail de produits pharmaceutiques
- 47742Commerce de détail de lunettes de correction, de lentilles et de lunettes de soleil
- 52310Pharmacies
- 52485Commerce de détail spécialisé de matériel photographique, optique et de pécision
- 47730Commerce de détail de produits pharmaceutiques en magasin spécialisé
- 47730Commerce de détail de produits pharmaceutiques en magasin spécialisé
- 47782Commerce de détail de matériel photographique, d'optique et de précision en magasin spécialisé
Your risk analysis on this company
AML Company ran Optifarm through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Trading, no proceedings· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
1 active establishment unit declared with the CBE.
Finances & financial health
Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).
Equity & result
| Financial year | Equity | Result | Turnover / gross margin | Headcount (FTE) |
|---|---|---|---|---|
| 2025 | €412,960 | €71,877 | €584,204gross margin | 2,4 |
| 2024 | €412,960 | €55,429 | €398,913gross margin | 2,2 |
| 2023 | – | – | - | – |
| 2022 | €432,960 | €198,497 | €413,461gross margin | 2,1 |
Financial ratios
Solvency, liquidity and profitability, computed year by year from the filed annual accounts.
Equity / balance sheet total
Current assets / debts due within one year
This year's filing does not carry the item the calculation needs.
Result for the year / turnover
This year's filing does not carry the item the calculation needs.
Operating result / turnover
Debts due after one year / balance sheet total
Result for the year / equity
Balance sheet structure
| Ratio | 2025 | 2024 | 2023 | Trend |
|---|---|---|---|---|
| Solvency | 16,8% 1,2% | 17,9% | - | |
| Liquidity | 1,07 x 0,19 | 0,88 x | - | |
| Net margin | - | - | - | - |
| Operating margin | - | - | - | - |
| Long-term debt | 55,1% 1,8% | 56,9% | - | |
| Return on equity | 17,4% 4% | 13,4% | - |
Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.
Filing history (49)▾
| Financial year | Filing | Filing type | Model | Source |
|---|---|---|---|---|
| 01/01/2025 → 31/12/2025 | 15/06/2026 | Initial | m81-f | BNB |
| 01/01/2024 → 31/12/2024 | 27/05/2025 | Initial | m81-f | BNB |
| 01/01/2023 → 31/12/2023 | 03/05/2024 | Initial | m81-f | BNB |
| 01/01/2022 → 31/12/2022 | 30/05/2023 | Initial | m81-f | BNB |
| 01/01/2021 → 31/12/2021 | 21/06/2022 | Initial | m81-f | BNB |
| 01/01/2020 → 31/12/2020 | 16/06/2021 | Initial | m81-f | BNB |
| 01/01/2019 → 31/12/2019 | 20/07/2020 | Initial | m01-f | BNB |
| 01/01/2018 → 31/12/2018 | 26/06/2019 | Initial | m01-f | BNB |
| 01/01/2017 → 31/12/2017 | 14/08/2018 | Initial | m01-f | BNB |
| 01/01/2016 → 31/12/2016 | 30/05/2017 | Initial | m01-f | BNB |
| 01/01/2015 → 31/12/2015 | 17/06/2016 | Initial | m01-f | BNB |
| 01/01/2014 → 31/12/2014 | 15/07/2015 | Initial | m01-f | BNB |
Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.
The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- MAATSCHAPPELIJKE ZETEL19 December 2024
- ONTSLAGEN - BENOEMINGEN17 November 2021
- ONTSLAGEN - BENOEMINGEN28 February 2006
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
What the Optifarm record does not say
Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.
Is Optifarm subject to anti-money-laundering obligations in Belgium?
Did Optifarm file its annual accounts on time?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2026
- 15 June 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m81-fFiled accounts2026-00163928
- 2025
- 27 May 2025Annual accounts filed·Financial year ended 31 December 2024 · Model m81-fFiled accounts2025-00107436
- 2024
- 3 May 2024Annual accounts filed·Financial year ended 31 December 2023 · Model m81-fFiled accounts2024-00082437
- 2023
- 30 May 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m81-fFiled accounts2023-00099341
- 2022
- 7 December 2022Articles of association · Appointments · Resignations · RestructuringView the notice22144206
- 21 June 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m81-fFiled accounts2022-20076118
- 2021
- 16 June 2021Annual accounts filed·Financial year ended 31 December 2020 · Model m81-fFiled accounts2021-20700485
- 2020
- 20 July 2020Annual accounts filed·Financial year ended 31 December 2019 · Model m01-fFiled accounts2020-32600454
- 2019
- 26 June 2019Annual accounts filed·Financial year ended 31 December 2018 · Model m01-fFiled accounts2019-24200288
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
Apotheek D'haen
VAN HOLDER STEPHAN
APOBEL
D'HAEN PHARMA
PHARMAHEALTH
Apotheek De Geyter
APOTHEEK SIMOENS R.
Apr. Kristin Van Wilderode
Van de Keere
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.